Resveratrol therapy modulates inflammatory biomarkers and reverses mechanical allodynia in rats subjected to a temporomandibular joint arthritis model

Read full text Summarise with VIRAT
Authors: Iala Thais de Sousa Morais, Vitória Farias de Oliveira, Thais Collioni de Oliveira, AMANDA STIEVEN, Alanis da Silva Melo, Wolnei Caumo, Dirson João Stein, Iraci Lucena da Silva Torres
Cited by: 0
References: 67

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Toothaches, headaches, and chronic illnesses, including trigeminal neuralgia and temporomandibular joint dysfunction, are common craniofacial pain conditions. Resveratrol, a polyphenolic compound characterized by its antioxidant and anti-inflammatory properties, has shown therapeutic potential across multiple neurological disorders. This study aimed to evaluate the antinociceptive, anti-inflammatory, behavioral, and neurochemical impacts of Resveratrol in rats experiencing chronic inflammatory orofacial pain. A unilateral intra-trigeminal neuralgia injection (50 µL) of Complete Freund’s Adjuvant in adult male Wistar rats was used to induce pain. Resveratrol at 20, 40, or 80 mg/kg was administered to SHAM (saline) and Pain rats for 14 days. Mechanical allodynia (von Frey test) and thermal nociceptive sensitivity (acetone test) were assessed. Cytokine levels (TNF-α, IL-10, and IL-4) were quantified in the spinal cord and brainstem. Animals treated with Resveratrol demonstrated a progressive recovery in mechanical thresholds over time, with RES40 and RES80 groups exhibiting significantly higher thresholds (day 17) compared to the Pain group. Increased grooming time was observed during the acetone test in rats submitted to the pain model (day 3), with no significant effects of treatment (day 17). The pain model significantly increased spinal cord levels of TNF-α and IL-4. All doses of Resveratrol effectively mitigated the elevation in TNF-α levels in the spinal cord, while only RES80 potentiated the increase in IL-4 levels induced by the pain model. Despite limitations related to the pharmacokinetic characteristics of RES, the results indicate that this compound holds translational potential as an adjuvant in the management of painful inflammatory conditions, including TMJ disorders.

Fields of Study & Subjects

Pain Mechanisms and Treatments Temporomandibular Joint Disorders Sirtuins and Resveratrol in Medicine

Publication details

Journal / source
Inflammopharmacology
Volume
34
Issue
5
Pages
3277–3292
Publication date
31 March 2026
Language
EN